Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial

INTRODUCTION: The PACS01 trial has demonstrated that a docetaxel addition to adjuvant anthracycline-based chemotherapy improves disease-free survival (DFS) and overall survival of node-positive early breast cancer (EBC). We searched for prognostic and predictive markers for docetaxel's benefit....

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jacquemier, Jocelyne, Boher, Jean-Marie, Roche, Henri, Esterni, Benjamin, Serin, Daniel, Kerbrat, Pierre, Andre, Fabrice, Finetti, Pascal, Charafe-Jauffret, Emmanuelle, Martin, Anne-Laure, Campone, Mario, Viens, Patrice, Birnbaum, Daniel, Penault-Llorca, Frédérique, Bertucci, François
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2011
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326551/
https://ncbi.nlm.nih.gov/pubmed/22044691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3051
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares